ロード中...
Molecular characterisation of TP53 mutated squamous cell carcinomas of the lung to identify putative targets for therapy
Personalised cancer treatment depends on identification of therapeutically relevant biological subgroups of patients for assessing effect of treatment and to discover new therapeutic options. By analyses in heterogeneous patient populations, the effects may be lost in noise. Squamous cell carcinoma...
保存先:
| 出版年: | Int J Cancer |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7540694/ https://ncbi.nlm.nih.gov/pubmed/32468587 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.33121 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|